Dynamic magnetic resonance tomography and proton magnetic resonance spectroscopy of prostate cancers in rats treated by radiotherapy

Invest Radiol. 2004 Jan;39(1):34-44. doi: 10.1097/01.rli.0000095472.37056.0b.

Abstract

Rationale and objectives: To establish an experimental setting for monitoring perfusion and metabolism in orthotopic prostate cancer at 1.5 T using dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) and 1H-MR spectroscopy (MRS).

Methods: Dunning rat prostate cancer cells were injected into the prostate by open surgery. Twelve tumor-bearing rats (5 of these irradiated) and 6 healthy controls were followed up using gadolinium-diethylenetriaminepentaacetic acid -enhanced dynamic MRI and 1H-MRS. Amplitude and the exchange rate constant kep were calculated (2-compartment model). From 1H-MR spectra, ratios of choline (Cho) and creatine (tCr) were calculated. All tumors were examined histologically.

Results: On DCE MRI parameter maps, tumors showed increased vascularization. kep and microvessel density were correlated (r = 0.97). Tumors showed elevated Cho/tCr and an unexpected lipid fraction (2.0-2.2 parts per million). Irradiation slowed tumor growth significantly. Changes of perfusion and metabolism could be detected in all tumors during follow up.

Conclusion: DCE MRI and 1H-MRS has potential to characterize orthotopic Dunning prostate cancer in rats, which is a promising model similar to human prostate carcinomas.

MeSH terms

  • Animals
  • Antigens, CD34 / analysis
  • Choline / analysis
  • Creatine / analysis
  • Disease Models, Animal
  • Immunohistochemistry
  • Magnetic Resonance Imaging / methods*
  • Magnetic Resonance Spectroscopy*
  • Male
  • Neoplasm Transplantation
  • Prostatic Neoplasms / metabolism*
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / radiotherapy
  • Protons
  • Rats
  • Staining and Labeling
  • Time Factors

Substances

  • Antigens, CD34
  • Protons
  • Creatine
  • Choline